As drug price target deadline looms, pharma companies weigh options

Taking stock of the drug industry, from the lab to the medicine chest

June 10, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | As drug price target deadline looms, pharma companies weigh options Trump's most-favored nation plan would tie U.S. drug prices to those in other countries. Pharma firms await details, worry about consequences. By Daniel Payne Merck's RSV antibody treatment for infants is approved by FDA The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment. By Helen Branswell STAT+ | 'People inside Moderna are afraid': As anti-vaccine climate intensifies, the company has much to lose The recent downturn in biotech has battered Massachusetts' world-renowned sector, and the political climate has only made it worse. By Jonathan Saltzman — Boston Globe TOLGA AKMEN/AFP via Getty Images Opinion: We have 'post-vaccination syndrome.' We are tired of being used to score anti-vax points Yale's LISTEN study of post-vaccination syndrome became a lightning rod for Covid policy critics. Study participants want new treatments, not politics. By Chad Abel-Kops, Kimberly M. Harmon, and Peg Seminario Opinion: RFK Jr.'s attack on vaccine experts endangers every American  RFK Jr.'s decision to fire ACIP's members will make it far more difficult for pediatricians to vaccinate children. By Richard Besser STAT+ | NIH restores DEI prohibition for grant recipients within hours of rescinding it After rescinding ban on grants going to institutions with DEI or Israel boycott policies, NIH officials say the ban is still in effect By Anil Oza

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser